台股 » 個股 » 智擎 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智擎

(4162)
可現股當沖
  • 股價
    87.7
  • 漲跌
    --
  • 漲幅
    0.00%
  • 成交量
    467
  • 產業
    上櫃 生技醫療類股
  • 310人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
智擎 (4162)籌碼相關-群益金鼎-延平 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw06/0106/1406/2807/1207/2608/1008/2409/0609/2010/0410/1811/0211/1611/3012/1412/2801/1001/2202/1402/2803/1203/2204/0104/1404/2405/06708090100110120Jul '24Sep '24Nov '24Jan '25Mar '25May '2560d90dAll

群益金鼎-延平 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/05/05486.15486.0887.7001,7640.00%
2025/04/3000.00190.2089.20-11,796-0.06%
2025/04/2800.00690.9290.50-61,790-0.34%
2025/04/25687.40687.8887.9001,7790.00%
2025/04/23187.1000.0087.4011,7730.06%
2025/04/1700.00190.0089.40-11,792-0.06%
2025/04/14284.90384.7085.10-11,833-0.05%
2025/04/111081.07780.1184.0031,8420.16%
2025/04/0900.00176.3076.50-11,844-0.05%
2025/04/01197.3000.0097.3011,7730.06%
2025/03/316.295.63695.8096.200.21,7710.01%
2025/03/285101.104100.63100.5011,7520.06%
2025/03/253.2105.9700.00104.503.21,7190.19%
2025/03/212107.5000.00106.5021,7140.12%
2025/03/201105.501106.50106.0001,7130.00%
2025/03/1700.002.2106.00105.00-2.21,714-0.13%
2025/03/144.2104.6000.00105.004.21,7130.25%
2025/03/1317103.4415103.93103.5021,7070.12%
2025/03/111106.0000.00107.0011,6970.06%
2025/03/103104.503105.50107.0001,6860.00%
2025/03/0400.001114.00114.50-11,634-0.06%
2025/03/0300.0012.5112.11112.50-12.51,620-0.77%
2025/02/2720.3109.867109.71109.0013.31,5680.85%
2025/02/263114.671.2115.92115.501.81,5530.12%
2025/02/2500.001113.50113.00-11,443-0.07%
2025/02/2400.000.4115.00115.00-0.41,431-0.03%
2025/02/190.2110.0000.00110.000.21,3960.01%
2025/02/130.2110.5000.00111.500.21,4130.01%
2025/02/1200.001113.00112.00-11,408-0.07%
2025/02/101118.501121.00118.5001,3370.00%
2025/02/062120.501.4119.68119.000.61,3290.05%
2025/02/0500.001111.00113.00-11,194-0.08%
2025/02/0400.005101.50103.00-51,201-0.42%
2025/01/15394.80393.1093.1001,3800.00%
2025/01/0900.00197.9094.60-11,341-0.07%
2025/01/0800.001104.00103.00-11,299-0.08%
2025/01/0600.001.1100.55101.50-1.11,259-0.09%
2025/01/03195.7000.0098.3011,2400.08%
2025/01/0200.00194.9093.60-11,235-0.08%
2024/12/13188.2000.0088.8011,2090.08%
2024/12/04195.2000.0094.6011,1640.09%
2024/12/03194.3000.0094.4011,1610.09%
2024/12/02294.5000.0094.4021,1580.17%
2024/11/2800.00392.9092.40-31,110-0.27%
2024/11/27195.8000.0094.1011,0950.09%
2024/11/22296.10294.8593.8001,0310.00%
2024/11/20297.4500.0096.5021,0180.20%
2024/11/1900.00396.5096.00-31,015-0.30%
2024/11/18599.00796.5096.50-21,010-0.20%
2024/11/151099.95599.9099.9059890.51%
2024/11/146105.335102.50101.5019710.10%
2024/11/1300.005106.50106.50-5946-0.53%
2024/11/125102.206102.67104.00-1916-0.11%
2024/11/111104.5000.00103.5018820.11%
2024/11/081102.501104.00103.0008730.00%
2024/11/072103.503103.83103.50-1852-0.12%
2024/11/069103.336102.75102.5038260.36%
2024/11/051107.003105.50106.00-2782-0.26%
2024/11/011105.007108.07105.00-6730-0.82%
2024/10/309101.505102.00102.0046170.65%
2024/10/2500.000.498.0097.40-0.4513-0.09%
2024/10/2400.00396.5098.30-3494-0.61%
2024/10/2300.00293.3093.70-2424-0.47%
2024/10/18187.3000.0086.8014500.22%
2024/10/11889.34688.3088.3025020.40%
2024/10/08390.30592.6491.10-2507-0.39%
2024/10/04188.5000.0088.7015410.18%
2024/09/30189.80189.4089.5005500.00%
2024/09/20188.80187.4087.4006440.00%
2024/09/05182.60283.5582.10-1689-0.15%
2024/09/02387.1000.0086.6037190.42%
2024/08/2600.00187.3086.70-1738-0.14%
2024/08/16184.70284.5084.60-1743-0.13%
2024/08/12284.30285.0084.9007800.00%
2024/08/05187.10283.2083.00-1764-0.13%
2024/08/02191.20392.8092.20-2741-0.27%
2024/08/0100.00794.6494.50-7736-0.95%
2024/07/31193.1000.0093.2017360.14%
2024/07/3000.00293.3093.60-2736-0.27%
2024/07/29294.6500.0094.5027360.27%
2024/07/26597.60196.0097.6047290.55%
2024/07/2300.00194.4094.50-1720-0.14%
2024/07/22192.6000.0092.0017180.14%
2024/07/191.197.6800.0094.201.17080.16%
2024/07/1700.00198.6098.20-1658-0.15%
2024/07/1600.00198.9097.00-1658-0.15%
2024/07/15198.9000.0098.4016630.15%
2024/07/12195.6000.0095.6016480.15%
2024/07/11196.1000.0095.2016500.15%
2024/07/09197.306100.7596.30-5668-0.75%
2024/07/0800.002100.50100.50-2655-0.31%
2024/07/0400.00296.0096.00-2626-0.32%
2024/07/03496.5500.0096.7046280.64%
2024/07/026.198.0100.0097.806.16230.97%
2024/07/0110.1100.9900.00101.0010.16101.65%
2024/06/272.196.3800.0095.702.15820.36%
2024/06/2600.00397.5097.60-3576-0.52%
2024/06/2100.00196.0093.70-1607-0.16%
2024/06/19394.3000.0093.8036370.47%
2024/06/1800.00796.4495.40-7633-1.10%
2024/06/1700.00496.0095.50-4644-0.62%
2024/06/1400.00197.1095.30-1655-0.15%
2024/06/1300.00396.9096.90-3651-0.46%
2024/06/12394.4000.0094.8036380.47%
2024/06/11394.7700.0095.4036360.47%
2024/06/06792.4100.0091.1076301.11%
2024/06/0500.00192.1092.90-1632-0.16%
2024/06/04191.3000.0090.8016470.15%
2024/05/24392.9000.0092.8038080.37%
2024/05/20196.9000.0096.9018650.12%
2024/05/1700.00297.4097.90-2872-0.23%
2024/05/15194.1000.0093.9019520.11%
〈焦點股〉智擎胰腺癌新藥展望正向 股價帶量衝高Anue鉅亨-2025/03/03
智擎胰腺癌新藥2024淨銷售額達標 5000萬美元授權金將入袋Anue鉅亨-2025/02/05
智擎 相關文章